1. Home
  2. SNY vs UMH Comparison

SNY vs UMH Comparison

Compare SNY & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • UMH
  • Stock Information
  • Founded
  • SNY 1994
  • UMH 1968
  • Country
  • SNY France
  • UMH United States
  • Employees
  • SNY N/A
  • UMH N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • UMH Real Estate Investment Trusts
  • Sector
  • SNY Health Care
  • UMH Real Estate
  • Exchange
  • SNY Nasdaq
  • UMH Nasdaq
  • Market Cap
  • SNY 123.6B
  • UMH 1.4B
  • IPO Year
  • SNY N/A
  • UMH N/A
  • Fundamental
  • Price
  • SNY $50.33
  • UMH $17.23
  • Analyst Decision
  • SNY Buy
  • UMH Strong Buy
  • Analyst Count
  • SNY 2
  • UMH 4
  • Target Price
  • SNY $62.50
  • UMH $21.00
  • AVG Volume (30 Days)
  • SNY 3.1M
  • UMH 369.6K
  • Earning Date
  • SNY 04-24-2025
  • UMH 05-01-2025
  • Dividend Yield
  • SNY 3.09%
  • UMH 5.23%
  • EPS Growth
  • SNY 39.56
  • UMH N/A
  • EPS
  • SNY 5.45
  • UMH 0.10
  • Revenue
  • SNY $48,817,552,946.00
  • UMH $243,777,000.00
  • Revenue This Year
  • SNY $5.35
  • UMH $10.24
  • Revenue Next Year
  • SNY $6.69
  • UMH $8.52
  • P/E Ratio
  • SNY $9.56
  • UMH $165.71
  • Revenue Growth
  • SNY N/A
  • UMH 8.17
  • 52 Week Low
  • SNY $45.80
  • UMH $14.73
  • 52 Week High
  • SNY $60.12
  • UMH $20.64
  • Technical
  • Relative Strength Index (RSI)
  • SNY 39.23
  • UMH 41.89
  • Support Level
  • SNY $51.67
  • UMH $17.01
  • Resistance Level
  • SNY $55.73
  • UMH $17.49
  • Average True Range (ATR)
  • SNY 0.88
  • UMH 0.35
  • MACD
  • SNY -0.09
  • UMH 0.00
  • Stochastic Oscillator
  • SNY 7.84
  • UMH 15.62

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

Share on Social Networks: